Physical therapy for stroke survivors has long relied on the physical presence and hands-on expertise of therapists walking alongside their patients. Now, a remarkable technological leap is reshaping this dynamic. Researchers at Northwestern University in collaboration with Shirley Ryan AbilityLab have unveiled a revolutionary rehabilitation system that forges a direct, real-time link between therapists and patients via robotic exoskeletons. This novel system, known as Therapist-Exoskeleton-Patient Interaction (TEPI), ushers in a new era of highly adaptive, personalized post-stroke gait therapy.

At the heart of TEPI lies a pair of lower-limb exoskeletons worn by the therapist and the stroke survivor, virtually coupled at the hips and knees through a sophisticated control interface. The virtual connection mimics the behavior of springs and shock absorbers, dynamically transmitting forces and movements between the two exoskeletons. This bidirectional, compliant coupling enables therapists to intuitively influence patient gait patterns in real time, offering a level of interaction that is vastly more nuanced than conventional robotic or manual therapies.

Traditional stroke rehabilitation often involves therapists physically assisting patients through limited aspects of movement, constrained by human strength and availability. In contrast, TEPI leverages robotics to augment the therapist’s capacity, delivering whole-body gait training that adjusts fluidly to the patient’s evolving performance. The hands-on adaptability of therapists is thus preserved but enhanced with robotic precision and scalability, facilitating more comprehensive, sustained walking practice without requiring multiple caregivers.

The core engineering breakthrough enabling TEPI is a control framework that models the mechanical interaction between therapist and patient exoskeletons as a coupled spring-damper system. This design imparts compliance and responsiveness, harmonizing the biomechanical inputs from both participants while preventing unnatural or jarring forces. By embedding this interactive virtual linkage, TEPI provides continuous haptic feedback to therapists, allowing them to modulate support, resistance, and corrective assistance in tune with patient movement intentions.

In a recent clinical evaluation published in Science Robotics, TEPI demonstrated superior outcomes compared to conventional therapist-guided treadmill training. Stroke survivors using the system achieved significantly greater joint range of motion, executed longer and higher stepping patterns, and maintained muscle activation at levels comparable to or exceeding standard therapy regimes. Importantly, patient motivation and enjoyment remained consistently high, underlining the system’s potential to foster engagement and adherence during demanding rehabilitation processes.

The TEPI platform addresses prominent limitations of current rehabilitation exoskeletons, many of which rely on rigid, preprogrammed gait cycles that lack real-time adaptability. By contrast, TEPI integrates therapist expertise directly into the robotic control loop, enabling instantaneous behavioral adjustments that match the patient’s unique recovery trajectory. This synergy of human judgment and machine assistance embodies a new paradigm in rehabilitation robotics, where technology serves to amplify, not replace, therapeutic skill.

José L. Pons, the project’s visionary leader and a professor at Northwestern, emphasizes that TEPI’s promise lies in its ability to unify the therapeutic closeness of manual training with the replicability and intensity of robotic interventions. Such hybrid systems are poised to transform stroke recovery protocols by bridging gaps between efficacy, accessibility, and individualized care. They not only alleviate therapist physical burden but also enhance the precision and personalization of rehabilitation exercises.

The development team included multidisciplinary experts spanning mechanical engineering, physical medicine, biomedical engineering, and robotics, fostering innovation at the interface of human-machine interaction and clinical practice. This collaboration ensured that TEPI’s control algorithms and mechanical design were continuously refined based on real-world clinical feedback, resulting in a system deeply attuned to both biomechanical and therapeutic demands.

Looking ahead, the research group plans to expand TEPI’s application beyond treadmill walking, exploring its integration into functionally critical daily activities such as overground ambulation, stair climbing, and sit-to-stand transitions. Longitudinal studies are also underway to assess the benefits of repeated therapy sessions over extended recovery periods. Additionally, efforts are progressing to miniaturize and streamline the technology for potential deployment in home environments, promising scalable remote rehabilitation solutions that can transcend geographic and logistical barriers.

TEPI’s pioneering approach was made possible by funding from the U.S. National Science Foundation’s National Robotics Initiative, reflecting the strategic importance of robotics in advancing healthcare outcomes. By embedding robotic exoskeletons within a responsive therapeutic framework, the system exemplifies how cutting-edge engineering can catalyze transformative changes in the treatment of neurological impairments.

This breakthrough not only advances rehabilitation science but also redefines the human role in therapy. TEPI empowers therapists to become active collaborators with their patients through enhanced, augmented physical connection, promoting a more effective and responsive recovery journey for stroke survivors. It stands as a shining example of innovation that is as empathetic as it is technological — a true step forward in restoring mobility and quality of life.

Subject of Research:
Robotic exoskeleton-assisted gait therapy for stroke rehabilitation through therapist-patient real-time interaction.

Article Title:
Therapist-exoskeleton-patient interaction for gait therapy

News Publication Date:
17-Jun-2026

Web References:
http://dx.doi.org/10.1126/scirobotics.adz9628

Image Credits:
Shirley Ryan AbilityLab

Keywords

Robotic exoskeletons, Robotics, Robotic gaits, Robotic walking, Physical therapy, Physical rehabilitation, Brain damage, Brain injuries, Brain ischemia, Neuromuscular diseases, Neurological disorders

In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have emerged primarily as breakthrough medications targeting metabolic disorders such as type 2 diabetes and obesity. Medications like Ozempic and Wegovy have revolutionized treatment protocols by improving glycemic control and promoting weight loss through mechanisms involving appetite regulation and insulin modulation. However, intriguing new research spearheaded by scientists at Rutgers University suggests that the influence of GLP-1 receptor agonists may extend well beyond metabolic pathways, potentially modulating complex behaviors associated with violence and aggression.

The Rutgers study, published in the esteemed journal Criminology, delves into the behavioral ramifications of GLP-1 receptor agonist usage among adults in the United States. This groundbreaking investigation focused on whether these medications could attenuate the well-documented links between impulsivity, alcohol consumption, and violent behavior—an intersection of psychological and physiological domains rarely explored in pharmacological research. Given the increasing prevalence of GLP-1 usage, understanding these potential secondary effects holds substantial public health significance.

Researchers employed data gathered from a 2025 nationwide survey encompassing over 7,500 U.S. adults, narrowing their primary analysis to a subgroup of 821 individuals who had a history of GLP-1 medication use. This cohort was meticulously categorized into current versus former users to discern if ongoing GLP-1 receptor activity correlates with measurable differences in violent behavior frequency. Violent behavior metrics were derived from validated self-reported scales encompassing acts ranging from physical fights and assaults to more severe offenses like robbery, allowing for a comprehensive behavioral profile aligned with criminological standards.

A pivotal discovery from the analysis was the pronounced moderation of the relationship between impulsivity and violent conduct among current GLP-1 users. The data revealed that the association strength between impulsivity—a critical psychological trait linked to poor decision-making and aggression—and violent actions was reduced by approximately 62% in active GLP-1 users compared to those who had discontinued use. Such a substantial attenuation suggests that GLP-1 receptor agonists may exert neurobehavioral effects that temper impulsive drives which frequently precipitate violent acts.

Complementing these results, the study also examined the interplay between alcohol consumption, impulsivity, and violence. Alcohol’s role as a disinhibitor and amplifier of aggressive tendencies is well established. Among current GLP-1 medication users, the correlation between alcohol intake and violent behavior was notably diminished, showing around a 52% reduction in association strength relative to former users. While these findings were somewhat less consistent across different analytic models, they broadly indicate that GLP-1 receptor agonists might mitigate alcohol’s exacerbation of violent impulses, potentially via neurochemical or systemic pathways that modulate inhibitory control.

The underlying neural mechanisms posited by researchers revolve around the interplay of GLP-1 receptor activation within the central nervous system. GLP-1 receptors are expressed not only peripherally but also in brain regions implicated in impulse control, reward processing, and executive functions, such as the prefrontal cortex and limbic structures. Activation of these receptors could conceivably influence neurotransmitter systems including dopamine and serotonin pathways, which are integral to regulating mood, impulse control, and aggression. This neuropharmacological modulation may resemble cognitive behavioral therapy in effect — attenuating the translation of impulsive urges into violent actions without necessarily eradicating impulsivity itself.

Daniel Semenza, lead author and director of research at the New Jersey Gun Violence Research Center, underscored the public safety implications of these findings. With GLP-1 drugs increasingly prescribed globally, it is paramount to deepen scientific understanding of their broader psychobehavioral consequences. Exploring how these medications might serve dual roles in metabolic regulation and behavioral modulation opens new vistas in the multidisciplinary fields of medicine, psychology, and criminology. Such knowledge could inform clinical decisions and policies aimed at reducing violence, a persistent societal challenge with profound public health ramifications.

Nevertheless, the authors caution that the study’s observational, cross-sectional nature precludes definitive causal inferences. While associations are compelling, longitudinal and experimental research designs are essential to elucidate temporal dynamics and confirm whether GLP-1 receptor agonists actively reduce violence risk or if the observed correlations reflect confounding factors. Future studies integrating neuroimaging, pharmacokinetics, and behavioral assessments could unravel the precise biological and psychological pathways mediating these effects.

Christopher Thomas, coauthor and assistant professor at Rutgers University-Camden, highlighted the similarity between the behavioral influences observed and therapeutic interventions like cognitive behavioral therapy. Such parallels suggest that GLP-1 receptor agonists may have untapped potential as adjunctive treatments for impulse control disorders or behavioral problems characterized by aggression. Their dual metabolic and psychobehavioral actions could redefine therapeutic strategies for complex patients with overlapping physiological and psychiatric needs.

Moreover, understanding these effects could broaden the scope of violence prevention frameworks. If GLP-1 receptor agonists contribute to weaker links between impulsivity, substance use, and violent behavior, integrating pharmacotherapy with social and psychological interventions might amplify public safety outcomes. This intersection of neurobiology and criminology exemplifies the innovative, interdisciplinary research needed to address entrenched societal issues.

In summary, the Rutgers study furnishes compelling preliminary evidence that GLP-1 receptor agonist medications, beyond their established metabolic benefits, may significantly dampen the behavioral pathways leading from impulsivity and alcohol consumption to violence. These findings urge a paradigm shift toward holistic evaluation of drug effects encompassing neural, behavioral, and social domains. As the prescribing landscape for GLP-1 medications continues to expand, vigilant research and nuanced understanding will be critical to harnessing their full therapeutic potential while safeguarding public health.

---

Subject of Research: People
Article Title: GLP-1 receptor agonist use and violent crime among US adults
News Publication Date: 17-Jun-2026
Keywords: Violence, Drug therapy, Weight loss, Mental health

In a groundbreaking study published in PNAS Nexus on May 23, 2026, researchers have unveiled compelling evidence that extreme risk protection orders (ERPOs), frequently known as “red flag” laws, substantially diminish the likelihood of arrests among individuals subjected to these legal interventions. This decline in arrests encompasses a broad spectrum of offenses, notably violent crimes and firearm-related offenses, and persists not only during the enforcement period of the orders but intriguingly continues well beyond their expiration. These findings are poised to reshape public policy discussions concerning firearm violence prevention strategies in the United States.

The context driving this research is a nationwide crisis of firearm violence, which as of 2024, has tragically culminated in over 43,000 deaths, with shootings in 2025 alone injuring approximately 40,000 individuals, excluding cases of suicide. Such staggering figures underscore the urgent need for efficacious interventions. ERPOs have emerged as a targeted legal mechanism whereby courts temporarily restrict firearm access for individuals deemed to pose an imminent threat to themselves or others. Currently, 22 states, alongside the U.S. Virgin Islands and the District of Columbia, have enacted distinct ERPO statutes, reflecting growing legislative momentum. California pioneered this policy approach in 2016, branding them Gun Violence Restraining Orders.

The retrospective cohort study analyzed detailed arrest data from 679 California residents subject to ERPOs between 2016 and 2019. Demographic profiling revealed a predominance of males (91.9%) with an average age slightly above 40 years. Ethnically, the cohort comprised mainly White individuals (59.9%), followed by Hispanic (19%) and Black populations (10.3%). Researchers meticulously compared arrest rates across three critical intervals: six months preceding the ERPO issuance, during the active order period, and the subsequent six months following order expiry. The scope of offenses under scrutiny included any form of arrest, violent crime, firearm-related offenses, and firearm-specific violence.

Quantitative analysis revealed that the presence of an ERPO corresponded with an impressive 55% reduction in arrests for any offense compared to the baseline six-month period prior. Arrests specifically for violent crimes plummeted by 71%, while firearm-related arrests witnessed a striking 76% decline. Most notably, firearm violence arrests decreased by an extraordinary 80% during the enforcement phase. These statistics not only affirm ERPOs’ immediate efficacy in curtailing dangerous behaviors but also highlight their targeted protective potential.

Perhaps more unexpectedly, the data indicated that the downward trend in arrests did not revert to pre-order levels once ERPOs expired. Instead, reductions persisted and even deepened in certain categories. Post-expiration, arrest rates for any offense decreased by 63%, violent crime arrests by 75%, firearm-related offenses by 70%, and firearm violence arrests by 63%. Such sustained effects provoke critical questions about the mechanisms through which ERPOs might exert enduring behavioral influence, potentially functioning as a catalyst for long-term risk amelioration.

While the study’s outcomes exude optimism, authors elucidate several methodological limitations. Primary among these is the reliance on arrest records as a proxy for criminal activity, a metric subject to inherent biases and imperfect capture of all unlawful behavior. Additionally, the exclusive focus on California’s ERPO implementation during a specific timeframe limits the generalizability of findings to other jurisdictions or more current contexts. Nonetheless, the robust statistical associations discovered furnish key empirical support for ERPOs’ role in comprehensive violence reduction frameworks.

Veronica Pear, the study’s lead investigator and a respected epidemiologist affiliated with the UC Davis Centers for Violence Prevention, articulates the multipronged utility of ERPOs. “While often conceptualized primarily for suicide prevention, our analysis elucidates their significant function in preventing interpersonal violence,” Pear asserts. This research thus broadens the conceptual paradigm, reinforcing ERPOs as a practical, evidence-based intervention capable of mitigating acute crises and producing enduring safety benefits.

This study also complements a growing body of literature that underscores ERPOs as instrumental in suicide prevention, consolidating their standing as a versatile tool in public health and criminal justice spheres. The convergence of findings across domains of self-directed and other-directed violence lends vital credence to expanding ERPO adoption and refining enforcement protocols, especially given the current societal imperative to stem firearm-related morbidity and mortality.

From a policy perspective, these insights furnish lawmakers with empirically grounded justifications for instituting or strengthening ERPO frameworks. Importantly, the study encourages a nuanced appreciation of ERPOs’ temporal dynamics, highlighting the necessity for continued engagement and perhaps supplemental interventions after an order lapses to sustain positive outcomes.

On the frontier of violence prevention research, the study paves avenues for further investigation into optimizing ERPO implementation, exploring differential impacts across demographic subgroups, and elucidating the behavioral psychology underlying observed arrest reductions. Such endeavors will be pivotal in tailoring ERPO policies that maximize protective effects while respecting individual rights and legal safeguards.

As firearm violence continues to exact a heavy toll on American communities, this research provides a beacon of evidence-informed hope. By harnessing the nuanced potential of ERPOs, stakeholders can better navigate the complex interplay of legal, public health, and social factors driving violence prevention and move toward a safer society.

Subject of Research: People

Article Title: Reduced incidence of arrest following an extreme risk protection order among respondents in California

News Publication Date: 23-May-2026

Web References:

• https://doi.org/10.1093/pnasnexus/pgag184
• https://cvp.ucdavis.edu/

References:

• Pear, V., et al. (2026). Reduced incidence of arrest following an extreme risk protection order among respondents in California. PNAS Nexus. DOI: 10.1093/pnasnexus/pgag184

Keywords: Gun violence, Public health, Crime, Criminology, Human social behavior

In the mountain villages of Guatemala’s Western Highlands, farmers are combining ancient Maya knowledge with modern sustainable farming techniques to protect their crops from pests and disease. Smallholders are creating homemade biopesticides using plants with strong smells and flavors to deter pests on their family plots. This is helping to cut back on the use of increasingly expensive agrochemicals, many of which have been labeled as dangerous to human health and linked to soil degradation. About 60 Guatemalan communities in the Western Highland departments of Sololá and Huehuetenango, as well as Chiquimula in the east, are working to revive these traditional techniques with support from the international development organization World Neighbors. Their focus is to restore and strengthen traditional knowledge, combining it with agroecological practices that help families produce surplus food they can sell to boost household incomes. “Traditional farming techniques are becoming popular because they are simple practices to apply, use local resources, and have proven to be effective,” Dayani Roche, a program associate at World Neighbors, told Mongabay via email. Rather than a single ancient recipe, farmers are using “a living combination of ancestral knowledge, local experimentation and more recent agroecological practices,” he said, which are “safer for families, soil, water and biodiversity than many chemical alternatives.” The Maya civilization, which once stretched across modern-day Central America, had a rich history of farming dating back to 2000 B.C.E. Its most celebrated agriculture system is the milpa, a form of intercropping that involves a mix of maize, beans and…This article was originally published on Mongabay

New DNA evidence reveals bed bugs tracked human expansion from ancient caves to modern cities.

Google's making a move in the mosquito business.

Common beans use a leaf receptor to turn caterpillar spit into a wasp-attracting scent.

This content is for members only. Visit the site and log in/register to read.